|
Volumn 218, Issue 1-2, 2014, Pages 259-260
|
OPRM1 polymorphism and lifetime suicide attempts among stabilized, methadone-maintained outpatients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA;
METHADONE;
MU OPIATE RECEPTOR;
OPRM1 PROTEIN, HUMAN;
ADULT;
CLINICAL TRIAL (TOPIC);
CONTROLLED STUDY;
DNA EXTRACTION;
FEMALE;
FRANCE;
GENE FREQUENCY;
GENETIC ANALYSIS;
GENETIC ASSOCIATION;
GENETIC RISK;
GENOTYPE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MAJOR DEPRESSION;
MALE;
METHADONE TREATMENT;
MOLECULAR PATHOLOGY;
OPIATE ADDICTION;
OPRM1 GENE;
OUTPATIENT;
PATIENT SELECTION;
PRIORITY JOURNAL;
RISK FACTOR;
SAMPLE SIZE;
SINGLE NUCLEOTIDE POLYMORPHISM;
SUICIDAL BEHAVIOR;
SUICIDE ATTEMPT;
GENETIC POLYMORPHISM;
GENETICS;
MIDDLE AGED;
OPIATE SUBSTITUTION TREATMENT;
OPIOID-RELATED DISORDERS;
PSYCHOLOGY;
STATISTICS AND NUMERICAL DATA;
YOUNG ADULT;
ADULT;
FEMALE;
HUMANS;
MALE;
METHADONE;
MIDDLE AGED;
OPIATE SUBSTITUTION TREATMENT;
OPIOID-RELATED DISORDERS;
OUTPATIENTS;
POLYMORPHISM, GENETIC;
RECEPTORS, OPIOID, MU;
SUICIDE, ATTEMPTED;
YOUNG ADULT;
|
EID: 84902084266
PISSN: 01651781
EISSN: 18727123
Source Type: Journal
DOI: 10.1016/j.psychres.2014.04.035 Document Type: Letter |
Times cited : (6)
|
References (5)
|